high-resolution mass spectrometry, respectively, of HCC827-ER5 versus parental cells.
KEGG-pathway cluster analysis based on 1343 genes whose expression levels significantly changed. Untargeted metabolomics analyses were performed using LC-qTOF-MS/MS. The data was acquired and processed using MultiQuant software, version 2.0 (AB Sciex). Metabolites showing significantly different levels HCC827-ER5 cells compared with HCC827 cells were subjected to metabolic pathway-enrichment analysis using MetaboAnalyst 4.0 (http://www.metaboanalyst.ca/). (B) Mitochondrially generated ROS in HCC827 and HCC827ER5 cells were determined using the MitoSOX Red Mitochondrial Superoxide Indicator. The viability assay was performed by CCK8 analysis. The cells were exposed to erlotinib for 72 h.
Supplementary methods

Metastasis analysis
A total of 3×10 6 cells suspended in 100 μL PBS were subcutaneously inoculated into the left and right flanks of 5-week-old BALB/c nu/nu athymic mice. Metastasis of the subcutaneously inoculated tumors was analyzed by detecting the disseminated tumor foci in distant tissues.
Tissues were removed for pathological analysis at the end point of the test or when the mouse was to die. After formalin-fixed 4-µm-thick sections were cut for hematoxylin and eosin (H&E) stain, the number and the area of disseminated tumor foci were counted and measured by using the NanoZoomer-S210 system (Hamamatsu, Japan). In bioluminescent imaging assay for metastasis, HCC827 cells transfected with luciferase (3×10 6 ) were subcutaneously inoculated into the left and right flanks of 5-week-old BALB/c nu/nu athymic mice. At the end of the test, the brains of the mice were isolated for detection of tumor metastasis basing on bioluminescent imaging analyzed by using the IVIS system (PerkinElmer, USA).
RNA-Seq analysis
Total RNA was extracted according to the manufacturer's instructions (Takara, 9767) from the indicated cell samples. RNA was subjected to RNA-Seq analysis on a BGISEQ-500 system by the Beijing Genomics Institute (BGI). FPKM was used to calculate the gene expression level.
Differentially expressed gene screening was performed using the Noiseq method. Gene Ontology (GO) annotation was based on the GO database (http://www.geneontology.org/). The KEGG pathway database (http://www.genome.jp/kegg/) was used to perform the pathway enrichment analysis of differentially expressed genes.
Untargeted metabolomics
Sample preparation: Cells were seeded in 6-well plates (2 × 10 5 /well) in triplicate and allowed to adhere overnight. Cell samples were extracted with 1 mL of MeOH: H 2 O mixture (8:2, v/v) and centrifuged for 15 min at 20,000 × g and 4 °C to settle any particulate matter.
Supernatants were taken separately for LC-MS/MS analysis. For UPLC/MS samples, three biological replicates were analyzed.
LCMS/MS analysis: The analysis was performed on a SHIMADZU Nexera UPLC System (consisting of a vacuum degasser, auto-sampler with thermostat, and binary pump) coupled to a TripleTOF™ 5600+ (AB Sciex). The separation of metabolites was carried out on a Waters ACQUITY UPLC BEH Amide column (2.1 mm × 100 mm, 1.7 μm). The mobile phase consisted of solvent A (0.1% aqueous ammonia and 20 mM ammonium carbonate in water) and solvent B (acetonitrile). The flow rate was set at 0.4 mL/min. The total elution time was 15 min and the elution condition was set as following: 0-2 min, 5% A; 2-9 min, 5%→55% A; 9-11 min, 55% A; including a 4 min equilibration time at 5% A. The metabolites were ionized using the electrospray ionization interface operating in negative ion mode and positive ion mode. IonSpray voltage was set at −4500 V (ESI-) and 5500 V (ESI+), curtain gas was kept at 35 psi, ion source temperature was 500 °C (ESI-) and 550 °C (ESI+), and nebulizing gas and drying gas were 55 psi. The collision energies were optimized with respect to the analyte between 15 eV and 45 eV to maximize the analyte response. Data was acquired and processed using MultiQuant software version 2.0 (AB Sciex).
